The probiotics are used to provide health benefits when consumed or administered in an adequate amount to the host body. Probiotics are live microorganisms that help treat or prevent disease when given in sufficient concentrations. These are available in many different forms, each with its own set of advantages. The most widely studied benefits of probiotics are that they promote a healthy digestive tract and immune system. The main forms of probiotics market are liquid and dry. Probiotics are produced in liquid forms such as probiotic liquid supplements, yogurt drinks, and fermented beverages like kefir and kombucha. The different ingredients include bacteria, and yeast, and are applied in functional food and beverages, dietary supplements, and animal feeds. These are used by human, and animals, and is sold through multiple distribution channels including hypermarket or supermarket, pharmacies or health stores, convenience stores, online retail, and others. The probiotics market research report is one of a series of new reports from The Business Research Company that provides probiotics market statistics, including probiotics industry global market size, regional shares, competitors with a probiotics market share, detailed probiotics market segments, market trends and opportunities, and any further data you may need to thrive in the probiotics industry. This probiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global probiotics market size grew from $66.9 billion in 2022 to $73.14 billion in 2023 at a compound annual growth rate (CAGR) of 9.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The probiotics market size is expected to grow to $101.89 billion in 2027 at a CAGR of 8.6%. The increasing tendency of customers towards healthy foods and nutrient-rich dietary supplements is expected to foster the probiotics market growth going forward. Self-care has evolved into a necessary component of the modern consumer's lifestyle. Furthermore, the growing emphasis on holistic health and immunity has resulted in some substantial dietary modifications among consumers. The use of vitamins, minerals, immunity-boosting meals, organic products, supplements, and other nutritional supplements has increased significantly. Probiotics are used as a supplement form in food and beverages and provide health benefits to the human digestive system. For instance, according to a survey conducted by Habit Health and Nutrition, an India-based nutrition tech company in 2021, Indians want to make eating healthy a priority in order to improve their physical and mental health. Over 70% of those surveyed said they'll prioritize dietary adjustments to improve their overall health and immunity, as well as reduce stress and anxiety. Therefore, the increasing tendency of customers towards healthy foods drives the growth of the probiotics market. Technological advancements have a key trend gaining popularity in the probiotic market. Major companies operating in the probiotics sector are focused on developing new technological solutions to improve the quality and life cycle of probiotic products. For instance, in April 2021, Cosmax NBT, a South Korea-based probiotics company launched Zeta probiotics technology which will help to preserve freeze-dried probiotics. Zeta Probiotics technology is a uniquely engineered freeze-drying technique that restores the cell walls and surface charges of probiotics. Freeze-drying probiotics, which can be used to change Delivery Formats, can harm goods and make them less effective in human digestion. To revive freeze-dried probiotics, Zeta probiotics technology uses a lysine-based combination. This increases their survivability in vitro under simulated gastric and duodenal stress. In January 2021, Novozymes, a Denmark-based biological solutions company acquired Microbiome Labs for a deal amount of $125 million. Novozymes will be able to expand its product portfolio and position itself in the probiotics market as a result of this acquisition. Microbiome Labs is a US-based company that offers probiotic and microbiome solutions. Major players in the probiotics market are Danone, Yakult Honsha Co. Ltd., Nestlé, Danisco, Chr Hansen Holding A/S, Probi AB, BioGaia, Kerry, Lifeway Foods, Lallemand Inc., PepsiCo Inc., Arla Foods Inc., Deerland Probiotics & Enzymes Inc., Evolve BioSystems, Protexin, Mother Dairy, General Mills Inc., i-Health Inc., Archer Daniels Midland Co., Cell Biotech Co. Ltd., Probiotical S.p.A., and Bright Diary. Asia-Pacific was the largest region in the probiotics market in 2022. The regions covered in the probiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the probiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The probiotics market consists of sales of yogurt , sauerkraut, miso soup, soft cheeses, kefir, sourdough bread, acidophilus milks. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global probiotics market is segmented - 1) By Form: Liquid, Dry 2) By Ingredient: Bacteria, Yeast 3) By Application: Food and Beverages, Dietary Supplements, Animal Feed 4) By End User: Human, Animal 5) By Distribution Channel: Hypermarkets Or Supermarkets, Pharmacies Or Health Stores, Convenience Stores, Online Retail, Other Distribution Channels

Probiotics dietary supplement refer to the live microorganisms when consumed in adequate amounts, confer a health benefit on the host. Probiotics dietary supplements are used to balance the friendly bacteria in the digestive system, help in preventing and treating diarrhea, and also improve some mental health conditions in humans. Probiotics dietary supplements are available in the form of capsules, powders, liquids, and other forms, with a wide range of strains and doses. Rather than single strains, they frequently contain mixed cultures of live microorganisms. The main sources of probiotics dietary supplements are yeast and bacteria. The yeast probiotics dietary supplements are used as dietary supplements as it contains high contents of vitamin B, proteins, amino acids, peptides, and trace minerals. The various forms are capsules, chewable and gummies, powders, tablets and soft gels, among others. The products are distributed through business-to-business, and business-to-consumer channels. The different applications are infant formula, food supplements, specialty nutrients, nutritional supplements that are used as human probiotics, and animal probiotics. The probiotics dietary supplements market research report is one of a series of new reports from The Business Research Company that provides probiotics dietary supplements market statistics, including probiotics dietary supplements industry global market size, regional shares, competitors with a probiotics dietary supplements market share, detailed probiotics dietary supplements market segments, market trends and opportunities, and any further data you may need to thrive in the probiotics dietary supplements industry. This probiotics dietary supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global probiotics dietary supplements market size grew from $6.4 billion in 2022 to $6.89 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The probiotics dietary supplements market size is expected to grow to $9.44 billion in 2027 at a CAGR of 8.2%. The prevalence of digestive disorders is expected to propel the growth of the probiotic dietary supplements market. Digestive disorder refers to any health problem that occurs in the digestive tract. Increasing incidences of digestive disorders are due to poor nutrition, an unbalanced diet, and lifestyle change. The probiotic supplements help in curing digestive diseases like intestinal inflammation, urogenital infections, and antibiotic-associated diarrhea by fighting against bad bacteria along with good bacteria in humans' intestines. According to the National Institute of Diabetes and Digestive and Kidney Disease, around 60 to 70 million people are affected by all digestive diseases in the USA in 2020. According to a survey on digestive health' of Indian families by ITC in 2021, about 56% of Indian families have reported digestive health issues. The prevalence of digestive disorders globally supports the growth of the probiotics dietary supplement market. Strategic partnerships are shaping the probiotic dietary supplements market. The companies operating in the probiotics dietary supplements market are collaborating on the development of advanced dietary supplements. For instance, in June 2021, Kaged Muscle, a US-based sports nutrition company collaborated with Lonza Group AG, a Switzerland-based pharmaceutical manufacturing company to develop Lonza's new probiotic ingredient in the US market named TWK10, which is expected to increase exercise endurance by up to 75%. Addtionallly, In June 2021, a Swedish company Probi partnered with Oriflame, Swiss multi-level marketing to introduce probiotic supplements across the world in the health segment. In November 2021, ADM, a US-based nutrition and agricultural origination and processing company acquired Deerland Probiotics & Enzymes, Inc., for an undisclosed amount. With this deal, ADM aims to power its growth and strengthen its innovation leadership in dietary supplements and functional foods and serve customers around the world. Deerland Probiotics & Enzymes, Inc., is a US-based provider of dietary supplements that use probiotics, prebiotics, and enzyme technology. Major players in the probiotics dietary supplement market are Probi, Vitakem Nutraceutical Inc., Chr. Hansen Holding A/S, ProbioFerm, Probium, UAS Laboratories, BioGaia, Contract NUTRA, Custom Probiotics Inc., Mercola Probiotics, Nebraska Cultures, Nutraceutix, NutraScience Labs, Winclove BV, and Bayer AG. North America was the largest region in the probiotics dietary supplements market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the probiotics dietary supplement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the probiotics dietary supplement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The probiotics dietary supplement market consists of sales of kefir, kimchi, kombucha, miso, sauerkraut, sourdough bread, tempeh and yogurt. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global probiotics dietary supplements market is segmented - 1) By Source: Yeast, Bacteria 2) By Form: Capsules, Chewables And Gummies, Powders, Tablets And Softgels, Other Forms 3) By Distribution Channel: Business To Business, Business To Consumer 4) By Application: Infant Formula, Food Supplement, Specialty Nutrients, Nutritional Supplements 5) By End Use: Human Probiotics, Animal Probiotics

The probiotics food and cosmetics are living bacteria ingested or administered to the body to provide health advantages. They are found in yogurt, beauty products, and various fermented foods. They also have various health benefits such as weight loss, and increased immunity. The main types of probiotic food and cosmetics are probiotics food and beverages, dietary supplements, and cosmetics. That food and beverages contain living microorganisms of a certain strain with a large number of cells that provide benefits to the host. The ingredients used are bacteria and yeast with various distribution channels such as hypermarkets/ supermarkets, pharmacies/ drugstores, specialty stores, and online. The probiotics food and cosmetics market research report is one of a series of new reports from The Business Research Company that provides probiotics food and cosmetics market statistics, including probiotics food and cosmetics industry global market size, regional shares, competitors with a probiotics food and cosmetics market share, detailed probiotics food and cosmetics market segments, market trends and opportunities, and any further data you may need to thrive in the probiotics food and cosmetics industry. This probiotics food and cosmetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global probiotics food and cosmetics market size grew from $52.53 billion in 2022 to $58.76 billion in 2023 at a compound annual growth rate (CAGR) of 11.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The probiotics food and cosmetics market size is expected to grow to $93.1 billion in 2027 at a CAGR of 12.2%. Customers preferred products with proven health benefits are expected to propel the growth of the probiotic’s foods and cosmetic markets. Probiotics have various health benefits such as increased immunity, and altered metabolism. They also act as functional foods, nutraceuticals, and food supplements to provide a healthy lifestyle to their consumers. Moreover, recent research has discovered that when children are given probiotics, their gut microbiota balance, intestinal cell proliferation, and immune response increase dramatically. According to the findings in 2021, the number of people using probiotics in the United States increased by 66%, accounting for 25% of all supplement users (compared to 15% of total users six months prior). When compared to six months ago, the percentage of U.S. consumers who used probiotics daily or more frequently climbed from 37% to 61%. Probiotic users increased by 188% to 26% of all supplement users in Italy (up from 9% six months ago), with an 83% increase in weekly compliance. Probiotic users increased by 108% to 48% of total supplement users among Chinese consumers (compared to 23% six months prior). While the survey's reach is limited, it reveals that consumers are aware of probiotics' ability to enhance immune function and are taking proactive steps to protect their health in the face of the global epidemic. Therefore, increasing customer prefer products with proven health benefits drives the probiotics foods and cosmetic market. Product development are shaping the probiotics foods and cosmetics market. Due to technological advancements, companies develop new products to satisfy consumer needs and provide an enhanced products with added features. In February 2021, BioGaia, a Sweden-based company that develops markets and sells a range of products with probiotics has developed next-generation probiotics with a focus on metabolic illnesses, including diabetes and associated problems with the help of bacteria that is very sensitive to oxygen. To cope with the sensitivity of oxygen, the company has patented a unique production technology whose information remains undisclosed. In November 2021, Archer Daniels Midland a US-based multinational food processing and commodities trading corporation company has acquired Deerland Probiotics and Enzymes for an undisclosed amount. The acquisition strengthens ADM's strategic investments to establish a full-scale global Health and Wellness business to assist fulfill the fast-growing demand for healthy foods, beverages, and supplements. Acquisitions such as Protexin and Biopolis, as well as organic capacity expansions to expand probiotics production at our Valencia site, have all contributed to our growth. Deerland Probiotics and Enzymes is a US-based company that specializes in developing science-backed solutions that benefit microbiome health, using probiotics, prebiotics, and enzyme. Major players in the probiotics food and cosmetics market are Probi Ab, Nestle, ADM, Danone, Yakult Honsha, BioGaia, Esse Skincare, L'Oreal, Glowbiotics LLC, TULA Skincare, Morinaga Milk Industry Co. Ltd., LaFlore Probiotic Skincare, Eminence Organic Skin Care, Estee Lauder, Aurelia London, Gallinee Microbiome Skincare, and Biomilk Skincare. Asia-Pacific was the largest region in the probiotic food and cosmetics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the market. The regions covered in probiotics food and cosmetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the probiotics food and cosmetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The probiotics food and cosmetics market consists of sales of probiotics food and cosmetics with ingredients such as lactobacillus rhamnosus GG and lactobacillus acidophilus. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global probiotics food and cosmetics market is segmented - 1) By Product Type: Probiotics Food and Beverages, Dietary Supplements, Cosmetics 2) By Ingredients: Bacteria, Yeast 3) By Distribution Channel: Hypermarkets/ Supermarkets, Pharmacies/ Drugstores, Specialty stores, Online

The probiotics in the animal feed refer to a live microbial feed additive that enhances the intestinal balance of the host animal. Probiotics are widely employed in animal feeding and are regarded as growth and health stimulators. Most probiotics used in animal nutrition are generated commercially and sold in liquid and solid forms. The main forms of probiotics in animal feed are dry and liquid. The dry probiotics are used in the animal feed in the form of dried powder form, tablets, and capsules. Dry probiotics come in a variety of shapes and sizes and are made using a freeze-drying method. The various sources of probiotics in animal feed include bacteria and yeast and fungi. They are used in feed of cattle, poultry, swine, aquaculture, and other applications. The probiotics in animal feed market research report are one of a series of new reports from The Business Research Company that provides Probiotics in animal feed market statistics, including probiotics in animal feed industry global market size, regional shares, competitors with probiotics in animal feed market share, detailed probiotics in animal feed market segments, market trends and opportunities, and any further data you may need to thrive in the probiotics in the animal feed industry. This probiotics in animal feed market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global probiotics in animal feed market size grew from $4.26 billion in 2022 to $4.62 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The probiotics in animal feed market size is expected to grow to $6.35 billion in 2027 at a CAGR of 8.2%. The growing demand for eggs and poultry meat contributes to the growth of probiotics in the animal feed market. The demand for eggs and poultry meat is increasing because of the rise in population, greater purchasing power, and urbanization. Moreover, increasing awareness about the nutrients and protein from eggs and meat are contributing towards their demand. Probiotics are used as an additive in the poultry feed, which keeps the poultry farm animals disease-free and boosts their immunity to produce more eggs and meat. For instance, in 2020, according to the Food and Agricultural Organisation of the United Nations, the global production of poultry meat increased from 9 to 133 million tonnes, and egg production increased from 15 to 93 million tonnes between 1961 and 2020. Poultry meat accounted for 40% of the total meat produced worldwide in 2020. Egg production increased by 150% in the last three decades. Thus, increased demand for eggs and poultry meat is expected to boost the demand for probiotics in the animal feed during the forecast period. Partnerships and collaborations is a key trend gaining popularity in the probiotics in the animal feed market. The companies operating in the probiotics in the animal feed market are focusing on establishing partnership with relevent technology companies to expand their product development activities and enhance their market reach. For instance, in September 2020, Proteon Pharmaceuticals, a Poland-based biotechnology company, partnered with DuPont Animal Nutrition. The partnership aims to use DuPont's reputable and trusted brand to help poultry producers in particular nations access Proteon's bacteriophage technology. In addition to improving Proteon's distribution capabilities and strengthening DuPont's product line, the partnership will help further reduce antimicrobial resistance (AMR) in farm animals. DuPont Animal Nutrition is a biotechnology research company that produces a wide range of feed enzymes, betaine, phytogenics, and probiotics. In January 2021, Novozymes, a Denmark-based biotechnology company specializing in research, development, and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients, acquired Microbiome Labs for $125 million. Through this acquisition, Novozymes will focus on probiotics for human use as a growth area. It offers the chance to advance our work in human health, expand its portfolio, and cement its leadership in the North American probiotics market. Microbiome Labs is an Illinois-based company that focuses on providing probiotic bacteriotherapy. Major players in the probiotics in animal feed market are Chr. Hansen, Koninklijke DSM N.V., DuPont, Evonik Industries, Land O'Lakes, Calpis Co., Ltd., Ohly, Lesaffre, Alltech, Novozymes, Unique Biotech, Archer Daniels Midland Company (ADM), Advance aqua bio technologies, Danisco A/S, and Kerry Group. Asia-Pacific was the largest region in the probiotics in animal feed market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the probiotics in animal feed market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the probiotics in animal feed market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The prebiotics in the amimal feed market consists of sales of lactobacillus, bacillus, streptococcus, pediococcus, enterococcus, bifidobacterium, and propionibacterium. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global probiotics in animal feed market is segmented - 1) By Form Type: Dry, Liquid 2) By Source Type: Bacteria, Yeast and Fungi 3) By Application Type: Cattle, Poultry, Swine, Aquaculture, Other Applications

Peptide antibiotics refer to antibiotics made up of peptides the physical rupture of cell membranes underpins the antibacterial activity. The peptide antibiotics are used to permeate bacterial membranes, collect within bacteria, and then interfere with bacterial functioning. The main types of peptide antibiotics are ribosomal synthesized peptide antibiotics and non-ribosomal synthesized peptide antibiotics. The ribosomal synthesized peptide antibiotics destroy or modify the drug, change the drug target, decrease or raise drug uptake, and substitute a different metabolic step as the medication's target. Ribosomal synthesized peptide antibiotics refer to antimicrobial peptides generated by ribosomes and produced by practically all species, from bacteria to plants and animals. The various drugs under peptide antibiotics are daptomycin, dalbavancin, telavancin, and other drugs used to treat several diseases such as skin infection, HABP/VABP, blood stream infection, and other diseases. The peptide antibiotics are used and distributed through hospitals, homecare, specialty clinics, and other distribution channels. The peptide antibiotics market research report is one of a series of new reports from The Business Research Company that provides peptide antibiotics market statistics, including peptide antibiotics industry global market size, regional shares, competitors with a peptide antibiotics market share, detailed peptide antibiotics market segments, market trends and opportunities, and any further data you may need to thrive in the peptide antibiotics industry. This peptide antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global peptide antibiotics market size grew from $4.23 billion in 2022 to $4.58 billion in 2023 at a compound annual growth rate (CAGR) of 8.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The peptide antibiotics market size is expected to grow to $6.22 billion in 2027 at a CAGR of 7.9%. The increase in the prevalence of various infectious diseases is expected to propel the growth of the peptide antibiotics market. Infectious diseases are illnesses caused by harmful micro-organisms such as bacteria, fungi, parasites, and others. The major reasons for the rise in infectious diseases are rapid urbanization, climate change, increasing risk of disease emergence, and others, which have increased the demand for peptide antibiotics. Peptide antibiotics physically rupture the cell membranes and underpins the antibacterial activity. For instance, in July 2022, according to the Australian Institute of Health and Welfare, an organization that provides data and statistics about Australia's welfare and health, the cases of notifiable infectious diseases in Australia grew from 2.89 million cases in 2020 to 7.02 million cases in 2021. It shows a significant growth in the total number of cases of infectious diseases. Therefore, the increase in the incidence of infectious is driving the growth of the peptide antibiotics market. The strategic partnership is a key trend gaining popularity in the peptide antibiotics market. Major companies operating in the peptide antibiotics market are entering into partnerships to expand their market and leverage each others resources. For intsance, in January 2022, Berkeley Lights, a US-based digital cell biology company, partnered with Aanika Biosciences. In this partnership, Aanika will leverage Berkeley Lights' high-throughput, functional screening service to swiftly find and refine functional antimicrobial peptides (AMPs) capable of eliminating dangerous bacteria, particularly those that cause foodborne disease outbreaks. Furthermore, the Beacon Optofluidic Platform will be used to identify peptides that are harmful to bacteria in order to develop a novel antibacterial tag, which will then be used in their bacterial spore-based barcoding technology to secure the food supply chain. Aanika Biosciences is a US-based biotechnology company. An increase in incidence of chronic diseases is expected to drive the peptide antibiotics market. Chronic diseases are illnesses that last a year or longer, demand ongoing medical attention, and limit daily activities. Chronic diseases are on the rise as a result of increased tobacco use, poor nutrition, physical inactivity, excessive alcohol consumption, and other factors. Peptide antibiotics are used to treat chronic diseases by administering the drug in the target area. For instance, in July 2021, the National Council on Aging, Inc., a US-based charitable organization, reported that over 85% of elderly people have at least one chronic illness, and health care spending rose to $3.8 trillion annually in the US. Also, according to a research report published by American Action Forum in September 2020, chronic disease prevalence and costs are rising in the United States. They are expected to keep rising as the disease prevalence among children and young adults rises. Chronic disease is a serious healthcare problem since the rising cost of chronic disease in the United States totals $3.7 trillion annually, around 19.6% of the country's gross domestic product. Therefore, the increasing prevalence of chronic conditions is fueling the growth of the peptide antibiotics market. Major players in the peptide antibiotics market are Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Theravance Biopharma, Pacgen Life Science Corporation, Kasten, Savara Pharmaceuticals, Merck KGaA, Madam Therapeutics, Allergan PLC., Dr. Reddy’s Laboratories Ltd., Sanofi, Fresenius Kabi AG, Novo Holdings A/S and Teva Pharmaceutical Industries Ltd. North America was the largest region in the peptide antibiotics market in 2022. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the peptide antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The peptide antibiotics market consists of sales of oral, intravenous, intramuscular and topical peptide antibiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global peptide antibiotics market is segmented - 1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-rRibosomal Synthesized Peptide Antibiotics 2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs 3) By Disease Outlook: Skin Infection, HABP/VABP, Blood Stream Infection, Other Diseases 4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Veterinary antibiotics refer to a class of animal medications that are used to treat infectious disease in animals by killing microorganisms such as bacteria and parasites by inhibiting the growth of their cell walls to fight infections and diseases in animals caused by bacteria and improve the animals' health conditions. The main product types of veterinary antibiotics include anti-parasitic, anti-bacterial, non-steroidal anti-inflammatory drugs, and other products. Non-steroidal anti-inflammatory drugs (NSAIDs) act as a bridge between the production and activity of prostaglandins (enzymes) implicated in inflammation. Approved veterinary NSAIDs are used in companion animal care to reduce the pain and swelling linked with osteoarthritis in dogs and horses. The administration of veterinary antibiotics includes premixes, injections, oral powders, oral solutions, and other administrations used on farm animals and companion animals. The veterinary antibiotics research report is one of a series of new reports from The Business Research Company that provides veterinary antibiotics statistics, including veterinary antibiotics industry global market size, regional shares, competitors with veterinary antibiotics share, detailed veterinary antibiotics segments, market trends and opportunities, and any further data you may need to thrive in the veterinary antibiotics industry. The veterinary antibiotics research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global veterinary antibiotics market size will grow from $1.86 billion in 2022 to $2.02 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global veterinary antibiotics market size is expected to grow to $2.7 billion in 2027 at a CAGR of 7.5%. An increase in the number of zoonotic diseases is driving the veterinary antibiotics market. Zoonotic diseases are infectious diseases caused by microscopic organisms, infections, and parasites that spread between animals and humans. Two of the most common zoonotic pathogens, salmonella and campylobacter, are present in the intestines of these animals. Zoonotic diseases are also a potential threat to humans as they get transferred through the food chain. A study conducted by the FoodNet (Centers for Disease Control and Prevention, USA) found that 24,484 foodborne illnesses, 5,677 hospitalizations, and 122 deaths are caused by zoonotic diseases. In addition, the highest incidences per 100,000 people in the USA are caused by infectious diseases such as campylobacter, salmonella, and shigella. Therefore, there is a need to diagnose these diseases in animals at an early stage, which is a major driver of the veterinary antibiotics market. The rising threat of antibiotic resistance is a major restraint for the veterinary antibiotics market. Antibiotic resistance in animals refers to the ability of a microbe to withstand the impact of an antibiotic that once successfully treated infections caused by the same type of microbe. This can be a result of using antibiotics more than the prescribed limit. In this regard, the European Union (EU) has approved various restrictions on veterinary antibiotics, including a ban on antibiotics for animals and prohibiting the usage of antimicrobials in food, which is restricting the growth of the veterinary antibiotics market. Increasing collaboration between companies is an emerging trend in the veterinary antibiotics market. Collaboration offers companies the opportunity to combine technologies and a wide range, more diversified products to work with, and it also improves the quality of the antibiotics and the speed at which they are produced. Therefore, companies in the veterinary antibiotics market are focusing on collaborations. For instance, in September 2022, GlobalVetLink, a US-based provider of software services and informatics solutions in the field of animals, collaborated with Veterinary Innovative Partners to install GlobalVetLink Compliance Assistant, a thorough SaaS platform developed to simplify animal health. The veterinary antibiotics prescription drugs market is regulated by Section 503(f) of the Food, Drug, and Cosmetic Act of FDA. According to this law, the veterinary antibiotic drug labels are mandated to include a caution statement that states that these drugs can only be used with the permission of a licenced veterinarian. The sale and use of antibiotic prescription drugs without a prescription is usually reported to the FDA and strict action is taken based on it. Hence, regulations such as these would regulate veterinary antibiotic manufacturers and sellers. Major players in the veterinary antibiotics market are Bayer AG, Boehringer Ingelheim GmbH, CevaSanteAnimale, Eli Lilly Company, ElanCo., Merck & Co., Sanofi, Virbac, Zoetis, and Crystal Pharma. North America was the largest region in the veterinary antibiotics market in 2022. Asia-Pacific was the second-largest region in the global veterinary antibiotics market. The regions covered in the global veterinary antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the veterinary antibiotics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The veterinary antibiotics market consists of sales of antivirals, antiprotozoals, antifungals, aminoglycosides, beta-lactams, fluoroquinolones, glycopeptides, and lipopeptides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global veterinary antibiotics market is segmented - 1) By Product: Anti-Parasitic, Anti-Bacterial, Non-Steroidal Anti-Inflammatory Drug, Other Products 2) By End User: Farm Animals, Companion Animals 3) By Administration: Premixes, Injections, Oral Powders, Oral Solutions, Other Administration

The animal antibiotics and antimicrobials refer to veterinary medications that work against bacteria or microorganisms by either killing bacteria/microorganisms or limiting their development and multiplication. These medications are used in animals to treat clinical diseases, to prevent or control common disease events, and enhance animal growth. The main types of animal antibiotics and antimicrobials include tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. Tetracyclines are bacteriostatic, and their mechanism of action is through reversible binding of bacterial 30S ribosomes and alteration of bacterial cytoplasmic membrane. They are also referred to as oral medication used in treatment of bacterial infections due to aerobic, gram-negative bacteria, mycoplasma, and others. These are delivered in different forms including premixes, oral powder, oral solutions, injection, and others. These medications are used in both companion and food-producing animals. The animal antibiotics and antimicrobials market research report is one of a series of new reports from The Business Research Company that provides animal antibiotics and antimicrobials market statistics, including animal antibiotics and antimicrobials industry global market size, regional shares, competitors with a animal antibiotics and antimicrobials market share, detailed animal antibiotics and antimicrobials market segments, market trends and opportunities, and any further data you may need to thrive in the animal antibiotics and antimicrobials industry. This animal antibiotics and antimicrobials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global animal antibiotics and antimicrobials market size grew from $4.68 billion in 2022 to $5.07 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The animal antibiotics and antimicrobials market size is expected to grow to $6.95 billion in 2027 at a CAGR of 8.2%. Rising demand for animal-derived food products is driving the growth of the animal antibiotics and antimicrobials market. Animal-derived food products such as milk, eggs, meat, and other act a major source of nutrition and plays a prominent role in human diet. The companies/institutions involved in production of animal-derived foods are focusing on developing healthy herd or disease-free herd through utilization of animal antibiotics and antimicrobials on precautionary basis. According to the data published in the Packaged Facts report on Global Meat & Poultry trends, global meat and poultry consumption is expected to reach 313 million metric tons in 2023, at a year-on-year growth rate of 1.4%. Therefore, increasing demand for animal-derived food products is expected to boost demand for animal antibiotics and antimicrobials during forecast period. Strategic partnership is a key trend gaining popularity in the animal antibiotics and antimicrobials market. The companies operating in animal antibiotics and antimicrobial sector are entering into strategic partnerships with relevant industry players for the research and development of innovative animal antibiotics and antimicrobials. In May 2022, Gnubiotics Sciences, a Switzerland-based biotech company working to solve microbiome-related health conditions in humans and animals, entered into a partnership with ADM, a US-based developer of human and health nutrition solutions, for commercializing new microbiome solutions for companion animal health and wellbeing. In August 2020, Elanco, a US-based pharmaceutical company that manufacturers medicines and vaccinations for pets and livestock, acquired Bayer’s animal health business unit for $6.89 billion. With this acquisition, Elanco will improve its research and development pipeline and broaden its range of animal health products. Bayer’s animal health business unit is a Germany-based pharmaceutical and life sciences company. Major players in the animal antibiotics and antimicrobials market are Boehringer Ingelheim, Zoetis Inc., Elanco Animal Health, Merck & Co. Inc., Phibro Animal Health, Vetoquinol SA, Lutim Pharma, Ceva Santé Animale, Dechra Pharmaceuticals PLC., Kyoritsu Seiyaku, Huvepharma Inc., Zydus, Indian Immunologicals Pvt. Ltd., Bayer Animal Health, Virbac Animal Health, and Phibro Animal Health Corp. North America was the largest region in the animal antibiotics and antimicrobials market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal antibiotics and antimicrobials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the animal antibiotics and antimicrobials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The animal antibiotics and antimicrobials market consists of sales of glycopeptides, ß-Lactam antibiotics, and polymixins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global animal antibiotics and antimicrobials market is segmented - 1) By Type of Product: Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins, Other Antimicrobials and Antibiotics 2) By Mode of Delivery: Premixes, Oral Powder, Oral Solution, Injection, Other Modes of Delivery 3) By Animal Type: Food-Producing Animals, Companion Animals

Food antioxidants are the molecules that neutralize the free radicals and destabilize the molecules to protect cells from damage. Some major food antioxidants are mainly found in fruits, vegetables, vitamins such as E and C, and other plant-based foods. The primary types of food antioxidants are natural and synthetic antioxidants. They are available in dry and liquid forms. The food antioxidants are derived from fruits and vegetables, oils, spices and herbs, botanical extracts, and gallic acid and are used in fats and oils, prepared foods, prepared meat and poultry, seafood, bakery and confectionery, plant-based alternatives, and nutraceuticals. The food antioxidants market research report is one of a series of new reports from The Business Research Company that provides food antioxidants market statistics, including food antioxidants industry global market size, regional shares, competitors with a food antioxidants market share, detailed food antioxidants market segments, market trends and opportunities, and any further data you may need to thrive in the food antioxidants industry. This food antioxidants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global food antioxidants market size grew from $1.67 billion in 2022 to $1.82 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The food antioxidants market size is expected to grow to $2.56 billion in 2027 at a CAGR of 8.9%. An increase in the use of food antioxidants to improve the shelf life of processed food products supported the growth of the market during the historic period. Antioxidants have been used in the food processing industry to prevent oxidation and improve flavor, aroma, and color. Antioxidants have also been used and valued in the treatment of a variety of diseases, including cancer and coronary heart disease. The rise in the use of food antioxidants to improve the shelf life of food products supported the growth of the food antioxidants market. For instance, in March 2021, according to the National Center for Biotechnology Information (NCBI), a US-based organization that provides information on science and health, fruits, vegetables, culinary herbs, and spices have health-protective properties due to the presence of low-molecular antioxidants, which protect cells and their structures from oxidative stress and damage. The antioxidants also provide a positive correlation between the consumption of whole fruits and vegetables and the prevention of diseases such as atherosclerosis, cancer, diabetes, and arthritis, as well as improved cardiovascular and neurological health, lower cancer incidence, increased longevity, and lower overall mortality. Players in the food antioxidants market are increasingly adopting mergers and acquisition strategies to expand the product portfolio and expand operations in different geographies.  Mergers and acquisitions give growth opportunities to the players in the industry to maximize revenues through geographic and product portfolio expansion. For instance, in April 2021, Kemin Industries, a leading ingredient manufacturer, acquired Proteus Industries Inc. for an undisclosed amount. Through this acquisition, Kemin expects to expand its portfolio by adding clean-label phosphate alternatives, meat block replacements, and fat block solutions, along with the technology and human resources that Proteus has to offer. Proteus Industries is a food ingredient manufacturer that develops clean-label protein ingredients. Also, in January 2020, Dupont, which is a leading chemical and bioscience company, entered into an agreement with International Flavors & Fragrances to merge their nutrition and industrial biosciences divisions. This merger is expected to benefit both companies and allow them to better serve their customers. In April 2021, Kemin Industries, a leading ingredient manufacturer, acquired Proteus Industries Inc. for an undisclosed amount. Through this acquisition, Kemin expects to expand its portfolio by adding clean-label phosphate alternatives, meat block replacements, and fat block solutions, along with the technology and human resources that Proteus has to offer. Proteus Industries is a food ingredient manufacturer that develops clean-label protein ingredients. Major players in the food antioxidants market are Archer-Daniels-Midland Company, BASF SE, Koninklijke DSM N.V., Kemin Industries, Inc., Eastman Chemical Company, Frutarom Ltd., Barentz Group, Camlin Fine Sciences, Kalsec Inc., E.I. Du Pont De Nemours and Company, Cargill Inc., Advanced Organic Materials, VDH Chem Tech Pvt Ltd., and Vitablend Nederland BV. Asia-Pacific was the largest region in the food antioxidants market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food antioxidants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the food antioxidants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The food antioxidants market consists of sales of synthetic food antioxidants such as butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), and propyl gallate (PG). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global food antioxidants market is segmented - 1) By Type: Natural, Synthetic 2) By Form: Dry or Liquid 3) By Source: Fruits and Vegetables; Oils, Spices, and Herbs; Botanical Extracts; Gallic Acid; Other Sources 4) By Application: Fats and Oils; Prepared Foods; Prepared Meat and Poultry; Seafood; Bakery and Confectionery; Plant-Based Alternatives; Nutraceuticals; Other Applications